Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GlucoTrack, Inc. - Common Stock (NQ:GCTK)

2.010 -0.570 (-22.10%)
Streaming Delayed Price Updated: 11:14 AM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,278,160
Open 2.310
Bid (Size) 2.000 (15,900)
Ask (Size) 2.010 (1,300)
Prev. Close 2.580
Today's Range 2.000 - 2.360
52wk Range 1.998 - 136.29
Shares Outstanding 910,688
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
From Lōkahi Therapeutics
Via Business Wire
News headline image
Emerging Growth DRK GLND APUS GCTK Stocks in the News
Via AB Newswire
Topics Artificial Intelligence

Performance

YTD
-96.5%
-96.5%
1 Month
-60.6%
-60.6%
3 Month
-59.5%
-59.5%
6 Month
-87.7%
-87.7%
1 Year
-97.7%
-97.7%

More News

Read More
News headline image
DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region
Via AB Newswire
Topics Artificial Intelligence
Unusual volume stocks in Thursday's session ↗
Via Chartmill
Which stocks are moving on Thursday? ↗
Via Chartmill
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
News headline image
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
From Glucotrack, Inc.
Via Business Wire
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform
From Lōkahi Therapeutics
Via Business Wire
News headline image
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
From Lōkahi Therapeutics
Via Business Wire
News headline image
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
From Lōkahi Therapeutics
Via Business Wire
Top movers in Friday's session ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Friday's session. ↗
Via Chartmill
News headline image
Glucotrack Announces $11.5 Million Financing
From Glucotrack, Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions
From Lōkahi Therapeutics Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business
From Lōkahi Therapeutics
Via Business Wire
News headline image
Glucotrack, Inc. Announces Reverse Stock Split
From Glucotrack, Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100
From Lōkahi Therapeutics Inc.
Via Business Wire
News headline image
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia
From Lōkahi Therapeutics
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
From Glucotrack, Inc.
Via Business Wire
News headline image
Glucotrack Announces $5.5 Million Financing
From Glucotrack
Via Business Wire
What's going on in today's after hours session ↗
Via Chartmill

Frequently Asked Questions

Is GlucoTrack, Inc. - Common Stock publicly traded?
Yes, GlucoTrack, Inc. - Common Stock is publicly traded.
What exchange does GlucoTrack, Inc. - Common Stock trade on?
GlucoTrack, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GlucoTrack, Inc. - Common Stock?
The ticker symbol for GlucoTrack, Inc. - Common Stock is GCTK on the Nasdaq Stock Market
What is the current price of GlucoTrack, Inc. - Common Stock?
The current price of GlucoTrack, Inc. - Common Stock is 2.010
When was GlucoTrack, Inc. - Common Stock last traded?
The last trade of GlucoTrack, Inc. - Common Stock was at 09/25/26 11:14 AM ET
What is the market capitalization of GlucoTrack, Inc. - Common Stock?
The market capitalization of GlucoTrack, Inc. - Common Stock is 1.83M
How many shares of GlucoTrack, Inc. - Common Stock are outstanding?
GlucoTrack, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.